Drug Pipeline

Metreleptin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
3
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06502990 Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With… Generalized Lipodystrophy Recruiting
NCT06679270 Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy Familial Partial Lipodystrophy Recruiting
NCT02262832 Compassionate Use of Metreleptin in Previously Treated People With Generalized… Lipodystrophy Active, Not Recruiting
Phase 2
NCT06305182 Metreleptin in Anorexia Nervosa Anorexia Nervosa Recruiting
NCT02262806 Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy Diabetes Active, Not Recruiting
Not specified
NCT02325674 MEASuRE: Metreleptin Effectiveness And Safety Registry Generalised Lipodystrophy Recruiting
Sponsors Running Metreleptin Trials
Amryt Pharma (3) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) Gabriella Milos (1)
Disease Areas
Diabetes (2)
Get alerts when Metreleptin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free